New Mexico
For New Mexico, new drug wac threshold is $400 for a 30-day supply; price increase % trigger is 10% in the previous calendar year or 16% over the previous two calendar years; reporting deadline is first reporting deadline June 1, 2025; generic/biosimilar trigger is 30% or more over the previous calendar year; statute is NM HB 33, recorded from its source on 2026-08-14; source re-checked 2026-09-29.
- State
- New Mexico our reading
- New drug WAC threshold
- $400 for a 30-day supply
- Price increase % trigger
- 10% in the previous calendar year or 16% over the previous two calendar years
- Reporting deadline
- first reporting deadline June 1, 2025
- Generic/biosimilar trigger
- 30% or more over the previous calendar year verified
- Statute
- NM HB 33 verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
What the source says
NM HB 33 requires drug manufacturers to report to the state data for any (1) drugs with a WAC of $400 or more for a 30-day supply, (2) course of treatment that is shorter than 30 days for a brand-name drug that has increased in WAC by 10% or more in the previous calendar year or by 16% or more over the course of the previous two calendar years, or (3) a generic drug or biosimilar that has increased in WAC by 30% or more over the previous calendar year.
— goodwinlaw.com, retrieved 2026-08-14
Source
- goodwinlaw.comhttps://www.goodwinlaw.com/en/insights/publications/2025/06/alerts-lifesciences-state-drug-transparency-laws